Sitemap
September 09, 2017 Articles
Filter by Available Specialty
- AAOS offers tips during Pain Awareness Month to reduce opioid use, misuse among patients
- Addition of durvalumab to nab-paclitaxel may benefit patients with lung cancer
- Addition of pembrolizumab to chemotherapy improves outcomes in advanced NSCLC
- Adjuvant imatinib beneficial for high-risk gastrointestinal stromal tumors
- Annual CT scan does not offer survival benefit for completely resected NSCLC
- Oral glucagon-receptor antagonist reduces HbA1c
- Osimertinib extends PFS in EGFR-positive lung cancer
- PATH receives $120 million to improve vaccine research
- PUBLICATION EXCLUSIVE: Around the world in 5 days: My personal premium surgeon story
- Two grants issued to study extracellular matrix, CVD